JP2021521267A5 - - Google Patents
Info
- Publication number
- JP2021521267A5 JP2021521267A5 JP2021501072A JP2021501072A JP2021521267A5 JP 2021521267 A5 JP2021521267 A5 JP 2021521267A5 JP 2021501072 A JP2021501072 A JP 2021501072A JP 2021501072 A JP2021501072 A JP 2021501072A JP 2021521267 A5 JP2021521267 A5 JP 2021521267A5
- Authority
- JP
- Japan
- Prior art keywords
- hvr
- amino acid
- acid sequence
- seq
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018081096 | 2018-03-29 | ||
| CNPCT/CN2018/081096 | 2018-03-29 | ||
| PCT/CN2019/080496 WO2019185035A1 (en) | 2018-03-29 | 2019-03-29 | Anti-pd-l1 antibodies and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521267A JP2021521267A (ja) | 2021-08-26 |
| JP2021521267A5 true JP2021521267A5 (enExample) | 2022-04-06 |
| JP7433285B2 JP7433285B2 (ja) | 2024-02-19 |
Family
ID=68060953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021501072A Active JP7433285B2 (ja) | 2018-03-29 | 2019-03-29 | 抗ｐｄ－ｌ１抗体およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12054548B2 (enExample) |
| EP (1) | EP3774920A4 (enExample) |
| JP (1) | JP7433285B2 (enExample) |
| KR (1) | KR20210016514A (enExample) |
| CN (2) | CN112424225B (enExample) |
| AU (1) | AU2019241345A1 (enExample) |
| CA (1) | CA3095076A1 (enExample) |
| MY (1) | MY204733A (enExample) |
| WO (1) | WO2019185035A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3187850A1 (en) | 2020-08-04 | 2022-02-10 | Bryan Glaser | Pd-l1 binding agents and uses thereof |
| BR112023016706A2 (pt) * | 2021-02-19 | 2023-10-31 | Seoul Nat Univ R&Db Foundation | Anticorpo ou um fragmento de ligação ao antígeno do mesmo, molécula de ácido nucleico, métodos para produzir um anticorpo ou um fragmento de ligação ao antígeno do mesmo e para detectar agrupamento de diferenciação 47 ou determinar uma quantidade de agrupamento de diferenciação 47 em uma amostra, e, uso do anticorpo ou de um fragmento de ligação ao antígeno do mesmo |
| CN114225023B (zh) * | 2021-12-22 | 2022-10-18 | 宝船生物医药科技(上海)有限公司 | 抗csf-1r抗体联合抗pd-l1抗体的应用 |
| WO2023193239A1 (en) | 2022-04-08 | 2023-10-12 | Peter Peizhi Luo | Anti-cd28 antibodies and methods of use thereof |
| WO2024107731A2 (en) * | 2022-11-14 | 2024-05-23 | Ablexis, Llc | Anti-pd-l1 antibodies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101704734B1 (ko) * | 2005-07-01 | 2017-02-09 | 이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. | 예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체 |
| MX356367B (es) * | 2008-12-09 | 2018-05-25 | Genentech Inc | Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t. |
| BR112014012819B1 (pt) * | 2011-11-28 | 2022-08-16 | Merck Patent Gmbh | Anticorpo anti-pd-l1 ou fragmento de ligação ao antígeno do mesmo e composição |
| TWI726608B (zh) * | 2014-07-03 | 2021-05-01 | 英屬開曼群島商百濟神州有限公司 | 抗pd-l1抗體及其作為治療及診斷之用途 |
| SG11201702401RA (en) * | 2014-10-14 | 2017-04-27 | Novartis Ag | Antibody molecules to pd-l1 and uses thereof |
| RU2766890C2 (ru) * | 2015-06-16 | 2022-03-16 | Мерк Патент Гмбх | Комбинированные способы лечения антагонистами pd-l1 |
| EP4086285A1 (en) * | 2016-02-25 | 2022-11-09 | Cell Medica Switzerland AG | Binding members to pd-l1 |
| US10059769B2 (en) * | 2016-06-13 | 2018-08-28 | I-Mab | Anti-PD-L1 antibodies and uses thereof |
| EP3559045A4 (en) * | 2016-12-23 | 2020-08-19 | REMD Biotherapeutics, Inc. | IMMUNOTHERAPY USING ANTIBODIES THAT BIND TO A TIMED DEATH LIGAND 1 (PD-L1) |
-
2019
- 2019-03-29 CN CN201980023860.8A patent/CN112424225B/zh active Active
- 2019-03-29 EP EP19778308.7A patent/EP3774920A4/en not_active Withdrawn
- 2019-03-29 AU AU2019241345A patent/AU2019241345A1/en not_active Abandoned
- 2019-03-29 MY MYPI2020005109A patent/MY204733A/en unknown
- 2019-03-29 WO PCT/CN2019/080496 patent/WO2019185035A1/en not_active Ceased
- 2019-03-29 KR KR1020207030994A patent/KR20210016514A/ko active Pending
- 2019-03-29 US US17/043,454 patent/US12054548B2/en active Active
- 2019-03-29 CN CN202310883785.0A patent/CN117362436A/zh active Pending
- 2019-03-29 CA CA3095076A patent/CA3095076A1/en active Pending
- 2019-03-29 JP JP2021501072A patent/JP7433285B2/ja active Active